Increasingly, patients with tuberculosis are receiving clinical care in managed care organizations as a result of enrollment in Medicaid or Medicare, or coverage under privately purchased insurance policies or employee benefit plans. This represents a change from the system that has been in place for decades, where the clinical care and public health functions concerning treatment and control of tuberculosis occurred primarily in local health departments. The separation of individual patient care from the public health aspects of tuberculosis control has created challenges for managed care administrators, medical providers, and public health officials. To assist in the integration of the goals of managed care and public health with respect to the prevention and control of tuberculosis, we developed a set of model contract specifications for use by purchasers of managed care and by managed care organizations concerning the management of patients with tuberculosis and other related public health issues. These specifications can assist health officials in continuing their leadership roles by ensuring that managed care contracts address public health needs.
cal and laboratory services are available, infection control, outbreak and contact investigations, implementation of screening Background and preventive therapy programs in high-risk populations, and quality assurance [2] . Tuberculosis (TB) is a classic example of a communicable After the TB sanatoria were closed during the 1960s and disease that is associated with both patient care and public 1970s, typically both clinical care and public health functions health implications. The patient care component includes the for TB control were carried out in the health department setting diagnosis and treatment of active disease, the testing of high- [3] . However, during the past 3 decades, there has been an risk individuals for latent Mycobacterium tuberculosis infection, and the treatment of infected individuals with preventive increasing trend toward the provision of clinical care for patherapy. The goal of the public health approach in the United tients with TB by the private sector. By 1995, Ç50% of the States is to ensure that patients with active disease are promptly care for patients with TB was provided either partially or totally identified and provided with the appropriate drug therapy, so by the private medical sector [4] . This separation of individual that they are rendered noninfectious and cured and cannot transpatient care from the public health aspects of TB control has mit the disease to others. In addition, this approach includes created challenges for private health care providers and public the identification of populations at high risk for latent TB infechealth officials alike, and has provoked debates as to the optitions and the implementation of screening and preventive thermal setting for the care of patients with TB [5] . apy programs among these groups [1] . Public health activities
More recently, the managed care transformation has inrelated to TB include surveillance, assurance that quality clinicreased this movement of patients with TB away from clinical care in health department settings [6] . Patients with TB may be enrolled in managed care organizations as a result of coverage under employee benefit plans, privately purchased insur-states have expanded coverage to include previously uninsured incorporated separately into the preexisting sections of a contract (e.g., inclusion of the coverage provisions in the contract's persons [8] . The vulnerable populations among the newly insured are likely to include persons at high risk for TB. By benefit section). These provisions are important to health officials because they attempt to address the multiple points at 1996, Ç75% of all privately insured individuals, 40% of all Medicaid beneficiaries, and ú10% of Medicare beneficiaries which public health agencies should interact with managed care organizations and the public health considerations which were members of managed care plans, and these numbers are expected to increase [9] . The shifting of the care of patients must be addressed in managed care settings. They are important to providers, who are the implementors of all negotiated agreewith TB into managed care plans, with the emphasis on management of costs, has raised new concerns in the public health ments and must be aware of their responsibilities. On one level, the model provides the contractor (managed community with regard to the ability to maintain adequate community TB control as well as to provide optimal managecare organization) with contract specifications on how to appropriately provide clinical care to patients with TB. The contract ment of patient care in light of these changes.
Because of the clinical care and public health components goes significantly further, however, in that each section includes specifications that are to ensure that the public health as well as the characteristics of an acute infectious disease and a chronic disease (long duration of treatment), TB is an ideal aspects of TB control are addressed. For example, with respect to services for inpatient treatment, the contract specifies that condition to demonstrate a model framework that integrates clinical care with public health care. The goal of managed care isolation rooms must be available for patients with TB who are infectious and that discharge should be planned in consultais to prevent and cure disease among members of the managed care plan. However, although the primary duty of managed tion with local health authorities who must consider where the patient will be living and whether he or she may pose a public care organizations is to their members, the organizations function within a larger community and their operations must be health risk to the community (e.g., if living in a hospice for AIDS patients or in a nursing home). These considerations, consistent with public health goals. On the other hand, the goal of public health is to ensure the health of the community-atalthough fundamental to the thinking of public health officials, must now be formalized because they are not intrinsic to the large, and public health officials see their duty as promulgating this approach among all health care providers in the commumanaged care model. In developing these model contract specifications, we have nity. The aim of the model contract specifications presented here (see appendix) is to unite these two visions of duty.
assumed that all TB clinical and outreach services (tuberculin skin-test screening, laboratory-based and radiographic diagnosis, and drug treatment including directly observed therapy The Model Contract Specifications -Uses and Basic
[DOT]) will be included within the scope of the agreement. In Assumptions the case of Medicaid, where most state plans cover services that extend beyond the scope of the managed care agreement, At the heart of the relationship between managed care purchasers and managed care organizations (contractors) lies the a state agency may elect to exempt certain TB-related services from the contract. These services may remain the direct covercontract, or enforceable agreement, concerning what is being bought and sold. A recently completed comprehensive review age responsibility of the state agency (e.g., DOT in some California counties, where the health department is reimbursed of contracts between large group purchasers (e.g., state Medicaid agencies) and managed care organizations throughout the directly by the state Medicaid agency on a fee-for-service basis [10]) or may be incorporated into other managed care ''carvecountry revealed that, with very few exceptions, the contracts did not address issues that are pertinent to clinical care for out'' agreements. In this case, the document should be modified to specify which services are the financial duty of the contractor patients with TB or the public health aspects of TB control. In light of this lack of TB-related contract specifications and and which are the duty of the state Medicaid agency, the local health agency, or another entity or agency that is paying for the potential for critical issues in TB management to go unaddressed without clarity in written agreements, we underthe services. Even in instances where financial responsibility for payment for care is carved out of the contract and remains took the development of model contract specifications for TB.
the direct responsibility of the state agency, the managed care organizations may still have administrative responsibility for The model contract specifications we present were designed primarily to be incorporated into agreements between state provision of the carved-out service for which they may be reimbursed on a fee-for-service basis. Medicaid agencies (purchasers) and managed care organizations. However, these specifications can serve as a prototype An additional premise of these model contract specifications is that, although they can and should identify all recommended for any written agreement between managed care purchasers and contractors that concerns the clinical management and pubservices and activities important to the treatment, prevention, and control of TB, the issue of risk sharing (i.e., the question lic health issues associated with patients with TB. These specifications may be used in contracts either as a self-contained of whether a managed care organization should be at full financial risk for some or all of these services) is a matter best set of provisions or as a series of requirements that can be / 9C57$$oc55 09-15-98 16:01:29 cida UC: CID left to individual contract negotiations. For example, a buyer Section 102 delineates the services that the managed care organization is obligated to cover and provide. Provisions are and contractor in a very low-risk state (i.e., low TB morbidity rates) might agree that the managed care organization should included to ensure treatment completion, e.g., DOT, limiting or waiving cost-sharing for treatments and drugs for patients assume full risk for all TB-related services. On the other hand, in a high-risk state, the buyer and contractor might agree on a with TB, and addressing homelessness and drug addiction. Untreated or improperly treated patients are at risk for developing stop-loss arrangement (a ceiling for the amount of loss a seller will assume) or might provide for fee-for-service reimbursedrug-resistant disease and for transmitting disease to others [12] . In addition, the provision of preventive therapy to persons ment as a general matter for certain services. The premiums for the different arrangements will vary accordingly.
with latent TB is addressed. As noted, this section is drafted to be as comprehensive as possible; individual purchasers may Finally, in light of the variations in state law, a number of the issues described in this document may be addressed in state elect to exempt certain services from their contracts altogether or to incorporate certain services in separate carve-out agreepublic health statutes and regulations [11] . In this case, the document should be modified to reference such statutes or ments. Section 103 addresses medical necessity, that is the standard regulations, as these would take precedence.
that will be used to determine if a requested service will be covered. It is designed to ensure that in both coverage determiThe Model Contract Specifications nations for individual members and the general distribution of resources within the plan, managed care organizations will The contract is divided into ten sections (table 1). The components of these sections were selected because they represent use a public health -oriented approach [2] . Herein, we include provisions to ensure prompt treatment (rapid authorization prothe principal elements of Medicaid managed care contracts. The numbering system conforms to standard contract practices.
cedures) and the consideration of risks posed by the patient to the public's health, which may necessitate additional vigilance Section 101 provides definitions, primarily of the medical terms used in the document. The readership of the document in monitoring including quarantine of certain patients. The section also addresses the need to adhere to nationally accepted will include medical providers, Medicaid administrators, managed care administrators, and attorneys. This section is deguidelines in managing patients [1 -2, 13 -23]. See table 2 for a summary of guiding principles for the management of patients signed to ensure comprehension of and agreement on the meaning of key terms.
with TB or tuberculous infection. Section 104 describes enrollment and disenrollment provisions and emphasizes the importance of continuity of care for patients with active TB. Interruptions in the treatment of pa- overall public health objectives. This project was designed to 9 . Modify therapy on the basis of drug susceptibility testing results. 10. Never add a single drug to a failing regimen.
identify the key issues that must be resolved in translating porting cases and suspects to the health department, inadequate contact investigations, or gaps in the drug formulary for drugs to treat multidrug-resistant disease. In areas of high TB morbidity, a specially designated TB liaison in the managed care Section 107 provides guidance on formalizing the critical relationship between the managed care organization and the organization may monitor the quality of care and serve as the link between patient providers and the local health department local health department. Several states include memoranda of understanding (MOU) requirements in service agreements with to ensure that optimal patient care and public health functions of TB control are carried out. In most areas, however, medical managed care contractors in order to promote working relationships between managed care organizations and local health providers will serve as the stewards of patient care and the link with public health authorities. agencies. Matters not resolved in these contract specifications but pertinent to the management of cases of TB can best be Infectious diseases physicians, particularly those with experience in health care epidemiology, may be particularly welladdressed through the use of this MOU process. However, the content of MOUs is typically outside the scope of the managed qualified to link the clinical and public health functions of population-based managed care [27, 28] . Such physicians alcare contract and their provisions are not incorporated into the / 9C57$$oc55 09-15-98 16:01:29 cida UC: CID ready address infection control and employee risk issues for e. Fixed-dose combination drugs -drug formulations that combine two or more drugs into one capsule or tablet. Useful TB in both inpatient and outpatient settings [29, 30] . Managed care organizations and public health agencies may benefit from in preventing the development of drug-resistant TB. f. High morbidity area -an area designated by a health the involvement of infectious diseases physicians during contract negotiations and in assessing how well specific contract agency as having a high prevalence of TB. g. Infectious TB patient -an individual who has active TB provisions are being implemented, particularly those which relate to the adequacy of clinical and laboratory services, as and who is determined to be capable of clinically transmitting the disease. discussed in Section 105.
Over time it will become increasingly important to develop h. Latent tuberculosis (also tuberculous infection) -an individual is presumed to have latent TB if he or she is infected model specifications for a range of other communicable diseases. Regardless of whether the issue is the management of with M. tuberculosis but does not have clinical or radiographic evidence of disease (usually has a positive tuberculin skin test). tuberculosis, the management of vaccine-preventable diseases, or the management of sexually transmitted diseases, aligning i. Local public health agency -the public health agency whose service area includes part or all of the service area served managed care practices with public health imperatives is essential to the integration of public health priorities into managed by the Contractor and has jurisdiction to address threats to the public health. It is possible that a managed care contractor's care practices. The George Washington University Center for Health Policy Research, in collaboration with the Centers for service area may encompass the service area of more than one local health agency. Disease Control and Prevention (CDC), is currently developing model specifications for additional communicable diseases, as j. Mycobacterium tuberculosis -the bacteria that causes TB. well as a number of other diseases and conditions.
The managed care industry and public health community are k. Source case -an individual with infectious TB who may have infected one or more individuals. working to address the issues outlined in this document [31 -33] . The pace of change is rapid, however, and it is not possible l. Tuberculosis suspect -an individual who is suspected of having active TB on the basis of a clinical assessment and for at this point for purchasers, medical providers, and affected health officials to simply rely on ''industry practice.'' As purwhom multiple drug therapy is usually prescribed but for whom (i) confirmatory laboratory results have not yet been received chasers of managed care, medical providers and health officials increasingly direct efforts to address these issues, industry pracor (ii) clinical diagnosis has not yet been made. This definition is designed to ensure appropriate management at the earliest tice can be expected to evolve. The model contract specifications described in this document are designed not only to meet possible date for all active TB cases. Thus, the definition includes suspects who may eventually not be officially counted a current pressing need, but to assist in pointing the way toward further industry development.
as cases for surveillance purposes. and provide or arrange (subcontractors are bound by contract terms, unless otherwise specified) for the following TB-related a. Active tuberculosis (TB) -An individual is presumed to have active TB if he or she is considered to be infected with screening services (which shall include a medical history, physical examination, and tuberculin skin test, as indicated in the Mycobacterium tuberculosis, has clinical or radiographic evidence of disease, and qualifies for drug therapy [34] . Also professional judgement of the health professional furnishing the screening service): known as tuberculosis.
b. Contact -any individual who is identified as having been (1) screening examinations for asymptomatic children and adults who are identified as high risk. Examinations exposed to someone with active TB (shared ''air space'').
c. Case management -services that (i) assist an individual shall be conducted in accordance with the most recent guidelines [18, 21] . For both children and adults, Contractor shall in gaining access to medical, social, educational, and other services (including housing and posthospital discharge serensure use of the Mantoux tuberculin test, with results read by trained personnel and recorded in millimeters of induravices) and (ii) promote the continuity of care and completion of treatment.
tion. b. TB-related diagnostic services -Contractor shall cover d. Directly observed therapy (DOT) -a direct, face-to-face contact in any location (including a community setting other and provide or arrange for the following diagnostic services (which shall include evaluation of members who may be TB than a health professional's office) between an individual with TB and a health care worker who is trained to observe patients contacts under Section 106): In the case of persons diagnosed with latent, but not active, TB, contractors shall furnish preventive therapy, based on curculin skin testing, and biopsies of affected organs [14] ; (4) HIV counseling and serodiagnostic services. rent guidelines [15] .
Contractor shall provide or arrange for hospitalization which Performance Measure for Covered Services -Contractor shall: may be medically necessary (in accordance with Section 103)
• Submit all provider manuals, memoranda, and other inforto carry out one or more diagnostic tests. mation which set forth covered screening, diagnosis, treatment, c. TB-related treatment services for persons diagnosed with and preventive therapy services described in this section includactive TB -Contractor shall provide or arrange for medically ing, in the case of Medicaid, services for which the state agency necessary care for individuals who are diagnosed with active has retained residual coverage and payment responsibility. TB. Treatment shall be available for both TB suspects and
• Submit written memoranda of understanding with each individuals whose diagnoses have been confirmed either clinilocal health agency in its service area regarding the consultation cally or through laboratory tests. Covered benefits shall include procedures that will be followed in determining coverage of the following care and services:
services in the case of TB-related diagnosis, treatment, and (1) inpatient hospital services in facilities with TB isolapreventive therapy services. tion capabilities and that are otherwise appropriately equipped and staffed to treat persons with clinically active shall not count consumption of TB-related screening, diagnosis, vider must provide or arrange for at least monthly sputum or treatment services, whether furnished directly or through smear examinations and cultures from patients with active referral or prescription. (In some cases managed care plans TB until culture results are documented as negative [15] ; establish across-the-board upper limits on network provider (4) pharmaceutical services (including isoniazid, rifamresource consumption, with economic sanctions applied for pin, pyrazinamide, ethambutol [or streptomycin] and drugs providers who exceed such upper limits. In light of the public to treat drug-resistant TB when necessary) -Contractor health importance of TB control, such disincentives to use shall cover all prescribed drugs in both regular and fixedscreening, diagnostic, or treatment resources would be deemed dose combination forms and shall not dispense a dosage inappropriate.) format or amount which is different from the one prescribed c. TB-related medical necessity standard -in making deterby the treating professional. Cost-sharing requirements minations regarding the medical necessity of coverage and proshould be waived if necessary in the case of persons with vision of TB-related screening, diagnosis, and treatment seractive TB; vices (including determinations regarding the modification of (5) discharge planning for hospitalized patients;
an oral or written treatment plan which is in effect at the (6) for patients with conditions that could complicate retime of enrollment), Contractor shall use nationally accepted covery, including but not limited to mental illness and addicguidelines [1 -2, 13 -23] and shall take into account: tion disorders, homelessness or unstable housing and HIV/ (1) the patient's overall health status including evidence AIDS, referral to providers and agencies that furnish housing of addiction disorders, mental illness, HIV infection, and and social services; other health and social factors (including living arrange-(7) DOT. Because DOT is designed to assure continuity ments) that could adversely affect or complicate successful and completion of treatment and thus lessen the potential treatment of the patient; for the spread of the disease in the community, contractors (2) clinical evidence of TB (including the presence of are expected to cover the service unless not deemed medidrug-resistant TB); cally necessary by the local health agency; (3) the risks posed by the patient to the public's health (8) case management services throughout the course of treatment to reduce the risk of missed visits and to assure (this definition is designed to ensure that decisions concern-/ 9C57$$oc55 09-15-98 16:01:29 cida UC: CID ing coverage and treatment are made in consultation with • Submit all written memoranda of understanding with each local health agency in Contractor's service area regarding the state and local public health authorities and specifically consider the risks posed to public health by the patient.) consultation procedures that will be followed in making coverage determinations for members receiving TB-related services. d. Determinations of medical necessity by public health agencies -determinations of medical necessity by a public health agency shall be binding for the Contractor with respect Section 104. Enrollment and Disenrollment of Members to any TB-related screening, diagnosis, or treatment service covered under this agreement.
a. Enrollment of members receiving treatment for TB -in the event that Contractor enrolls an individual who is receiving e. Court or executive agency-ordered treatment -Contractor shall be bound by any treatment order that is issued by a TB-related treatment at the time, Contractor shall adhere to any treatment plan which has been developed for the member court of competent jurisdiction or an agency with the administrative authority to order treatment of individuals with infecprior to enrollment until treatment is completed. Contractor may modify the treatment plan only in accordance with the tious disease.
f. Prior authorization procedures for TB-related coverage terms of this agreement. b. Disenrollment of members receiving treatment -in the or referral requests -in the case of requests for TB-related diagnosis or treatment services or for referrals to providers event that an individual ceases to be an enrolled, Contractor shall immediately notify the public health agency and shall experienced in the diagnosis and treatment of TB, Contractor shall determine the medical necessity of the diagnosis or treatcontinue to furnish treatment until completed or for 30 days, whichever occurs first. ment request and shall communicate its determination to the member's provider, the patient, and the local health agency within 24 hours of receipt. Denials of requests for diagnosis (1) hospitals equipped with (AFB) isolation capabilities for persons with TB; Such review shall be carried out by an impartial decision-maker who was not involved in the initial decision to deny coverage.
(2) clinical providers with experience in treatment of indig. Free or discounted care not a factor in coverage determividuals with TB; nations -in making coverage determinations under this part, (3) referral providers specializing in the treatment of TB Contractor may not deny or reduce coverage for covered serfor individuals who, in the opinion of experienced providers, vices on the ground that such services are available at a substanhave complex cases of TB requiring subspecialty consultatial discount or free-of-charge through a local health agency tion or management (e.g., TB plus a complicating morbidity, or other program, provider, or agency. a complex case of TB, or multidrug-resistant TB). h. Treatment of quarantine plans -Contractor shall provide (4) laboratories for the provision of both diagnosis and or arrange for care and services which are identified in a quarantreatment-related testing services that maintain expertise in tine plan developed by a state or local health agency and which mycobacteriology and that conform to national guidelines are contained in the Contractor's service agreement. If the [17] (laboratories must be able to comply with the timeliness quarantine facility is a medical facility, all costs of institutionalrequirement applicable to laboratory services as specified in ization are covered under this agreement.
Section 106 (e)); i. Consideration of bacille Calmette-Guérin (BCG) immuni-(5) all other providers necessary to the proper execution zation status -in reviewing requests from health care providers of this section, including appropriately trained case managers for diagnosis or preventive therapy services, Contractor shall and DOT specialists. not use BCG immunization history as a sole basis for denying b. Payment of local health agencies -in the event that ensuch requests.
rollees receive TB-related services covered under this contract j. Drug substitution -Contractor shall engage in drug subfrom a provider identified in this subsection, Contractor shall stitution practices for TB-related prescribed drugs and biologireimburse such provider (regardless of provider's network stacals only if the substitution is approved by the public health tus) for services furnished at the same rate that would be paid agency.
to a network provider for the same service, unless Contractor can demonstrate through written information that the member Performance measure -Contractor shall:
has received or is receiving the same service from a network • Submit all provider manuals and information transmittals provider. Providers covered under this subsection are those that describe for providers the medical necessity standard appliworking in local health agencies, the Indian Health Service, cable to TB-related reviews as well as manuals explaining federally qualified health centers, and clinics operated by disContractor's procedures for making medical necessity determinations and reviewing denials of coverage.
proportionate share hospitals. programs) which shall address the following matters:
(1) the status of the local health agency as a provider of one or more covered TB-related screening, diagnosis or Section 106. Access Standards treatment services; a. Diagnosis of TB -Contractor shall treat as a request for (2) procedures for conferring on matters related to the emergency medical care any request for TB-related diagnosis diagnosis and treatment of TB cases including coverage deor treatment services which is made by a network provider, a terminations; local health agency, or any other medical, educational, social, (3) exchange of treatment plans between Contractor and correctional facility (in the case of members who remain eligithe public health agency; ble for Medicaid), other institution, or individual. (This provi-(4) procedures to be followed by the local health agency sion is intended to clarify that managed care contractors are and other providers, agencies, institutions, and individuals expected to furnish the services described in this document when referring to the Contractor for diagnosis and treatment regardless of whether the request to obtain such services comes members who are suspected of having TB or who are susfrom a medical professional, any other community organization pected contacts; or agency, or an individual. If the person who needs the service (5) data relating to individuals receiving TB-related diagis a member of the contractor's plan, then the contractor is nosis or treatment services which will be furnished by Conexpected to furnish the necessary care and may not refer the tractor and its providers to the local health agency as well requester to a local health agency unless such a referral constias data to be furnished to Contractor by the local health tutes the specific, agreed-upon course of action under a memoagency; randum of understanding between the contractor and a local (6) procedures to be followed when the local or state health agency.) health agency conclude that quarantine of a member of Conb. Management of TB contacts -Within 7 days of notificatractor is necessary; tion Contractor shall medically evaluate members who are iden-(7) responsibilities of the parties for notifying members tified as TB contacts and initiate appropriate treatment and who are suspected contacts; preventive therapy in accordance with the requirements of this (8) role and responsibility of the Contractor during an document [13] . Contractor shall notify the local health agency investigation of an outbreak by a local health agency; of any member who is a contact and who fails to appear for (9) procedures for ongoing discussions of current cases evaluation.
by Contractor and the local health agency; c. Geographic access -Contractors shall ensure access to (10) individuals who will be designated by Contractor appropriate sources of treatment and shall include payment and the local health agency as TB-related liaisons; of transportation costs where necessary. Travel time must be (11) procedures for addressing issues related to nonreasonable in consideration of the need to treat a communicable compliant patients or patients who have missed appointments disease.
for one or more treatment services. d. Interpreter and translation services -in the case of perPerformance measure -Contractor shall: sons receiving care for active tuberculosis, Contractor shall
• Submit a signed memorandum of understanding along provide for interpreter and translation services for both medical with all relevant appendices and attachments prior to commencand case management services.
ing services. e. Coverage standards for laboratory services -in the case of laboratory services furnished for the diagnosis or treatment of TB, Contractor shall ensure completion and notification of Section 108. Quality Assurance AFB sputum smear results within 24 hours, culture results a. Practice guidelines -Contractor shall disseminate to all within 2 to 3 weeks, and drug susceptibility tests within 4 network providers TB-related practice guidelines that are to be weeks of receipt of specimen [17] .
based on nationally accepted guidelines [1 -2, 13 -23] and which are to be updated as such guidelines are updated. Performance measures -Contractor shall:
• Submit all provider manuals and provider instructions that b. Clinical studies -in assessing the quality of its TB program, Contractor shall conduct clinical studies which are deinclude instructions to network providers regarding time lines for diagnosis and treatment of members with TB.
signed to measure the timeliness and appropriateness of its / 9C57$$oc55 09-15-98 16:01:29 cida UC: CID diagnosis and case management services. Such studies shall, • Submit the number and percentage of all members receiving treatment for TB whose reports, as required in this subsecat a minimum, consider the following factors:
(1) percentage of patients with active TB who are placed tion, have been submitted to the local health agency. on the recommended three or four-drug TB treatment regimen [15] ; Section 110. Confidentiality (2) the percentage of patients with active TB whose initial specimens were evaluated for drug susceptibility; a. Safeguarding patient confidentiality -in treating persons c. Outcomes measurement -Contractor shall keep and rewho are receiving TB-related services, Contractor shall comply port periodically to local health agencies individual and aggrewith all federal, state, and local laws relating to protection of gated data regarding outcomes of its TB treatment services.
patient confidentiality and the management of medical records. Such data shall, at a minimum, include the following [35] :
(1) the number and percentage of all members with active TB whose sputum cultures convert from positive to negative
